SI-BONE, Inc.
As of Oct 22, 2026, SI-BONE is in Stage 2, the uptrend phase, now in week 13 (since Jul 28, 2026). It closed at $21.56, at its 52-week high and above its 200-day average, which is falling.
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care
Is SIBN early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
SIBN among Medical Devices22nd of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …22 | SIBN | Stage 2 · wk 13 | 81 | +15.9% |
SI-BONE: quick answers
What stage is SI-BONE in?
As of Oct 22, 2026, SI-BONE (SIBN) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 28, 2026 and is in week 13. What the four stages mean
Is SI-BONE in an uptrend?
Yes. SI-BONE is in a Stage 2 uptrend. It trades 32.0% above its 200-day average, which is falling.
How far is SI-BONE from its 52-week high?
SI-BONE closed at $21.56 on Oct 22, 2026, at its 52-week high. Its 52-week low is $11.61.
How has SI-BONE performed over the past year?
As of Oct 22, 2026, SI-BONE is up 38.9% over the past year and up 8.9% so far in 2026.
Which sector and industry is SI-BONE in?
SI-BONE is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.